{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:59:51Z","timestamp":1790150391901,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"DOI":"10.1007\/s00381-026-07471-x","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:08:30Z","timestamp":1790100510000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nit2\/\u03c9-amidase as a potential non-invasive diagnostic marker for moyamoya disease"],"prefix":"10.1007","volume":"42","author":[{"given":"Tyra","family":"Martinez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Sesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Zurakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Shan","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Heuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aram","family":"Ghalali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"7471_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.661578","author":"BM Fox","year":"2021","unstructured":"Fox BM, Dorschel KB, Lawton MT, Wanebo JE (2021) Pathophysiology of vascular stenosis and remodeling in moyamoya disease. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2021.661578","journal-title":"Front Neurol"},{"key":"7471_CR2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10141","author":"A Gupta","year":"2020","unstructured":"Gupta A, Tyagi A, Romo M, Amoroso KC, Sonia F (2020) Moyamoya disease: a review of current literature. Cureus (New York NY). https:\/\/doi.org\/10.7759\/cureus.10141","journal-title":"Cureus (New York NY)"},{"key":"7471_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.spen.2022.101002","volume":"43","author":"LL Lehman","year":"2022","unstructured":"Lehman LL, Kaseka ML, Stout J et al (2022) Pediatric moyamoya biomarkers: narrowing the knowledge gap. Semin Pediatr Neurol 43:101002. https:\/\/doi.org\/10.1016\/j.spen.2022.101002","journal-title":"Semin Pediatr Neurol"},{"key":"7471_CR4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0804622","author":"RM Scott","year":"2009","unstructured":"Scott RM, Smith ER (2009) Moyamoya disease and moyamoya syndrome. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMra0804622","journal-title":"N Engl J Med"},{"key":"7471_CR5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.wneu.2021.11.026","volume":"159","author":"M Velo","year":"2022","unstructured":"Velo M, Grasso G, Fujimura M et al (2022) Moyamoya vasculopathy: cause, clinical manifestations, neuroradiologic features, and surgical management. World Neurosurg 159:409\u2013425. https:\/\/doi.org\/10.1016\/j.wneu.2021.11.026","journal-title":"World Neurosurg"},{"key":"7471_CR6","doi-asserted-by":"publisher","DOI":"10.3171\/2011.3.FOCUS1150","author":"DG Weinberg","year":"2011","unstructured":"Weinberg DG, Rahme RJ, Aoun SG et al (2011) Moyamoya disease: functional and neurocognitive outcomes in the pediatric and adult populations. Neurosurg Focus. https:\/\/doi.org\/10.3171\/2011.3.FOCUS1150","journal-title":"Neurosurg Focus"},{"key":"7471_CR7","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X19666210716114016","author":"X Zhang","year":"2022","unstructured":"Zhang X, Xiao W, Zhang Q et al (2022) Progression in moyamoya disease: clinical features, neuroimaging evaluation, and treatment. Curr Neuropharmacol. https:\/\/doi.org\/10.2174\/1570159X19666210716114016","journal-title":"Curr Neuropharmacol"},{"issue":"4","key":"7471_CR8","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3171\/2018.10.PEDS18582","volume":"23","author":"S Jernigan","year":"2019","unstructured":"Jernigan S, Storey A, Hammer C et al (2019) Moyamoya syndrome and PHACE syndrome: clinical and radiographic characterization of the intracranial arteriopathy and response to surgical revascularization. J Neurosurg Pediatr 23(4):493\u2013497. https:\/\/doi.org\/10.3171\/2018.10.PEDS18582","journal-title":"J Neurosurg Pediatr"},{"issue":"6","key":"7471_CR9","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3340\/jkns.2015.57.6.408","volume":"57","author":"JH Phi","year":"2015","unstructured":"Phi JH, Wang K-C, Lee JY, Kim S-K (2015) Moyamoya syndrome: a window of moyamoya disease. J Korean Neurosurg Soc 57(6):408","journal-title":"J Korean Neurosurg Soc"},{"key":"7471_CR10","doi-asserted-by":"publisher","DOI":"10.3340\/jkns.2015.57.6.415","author":"ER Smith","year":"2015","unstructured":"Smith ER (2015) Moyamoya biomarkers. J Korean Neurosurg Soc. https:\/\/doi.org\/10.3340\/jkns.2015.57.6.415","journal-title":"J Korean Neurosurg Soc"},{"key":"7471_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.525","author":"Q He","year":"2024","unstructured":"He Q, Li J, Tao C et al (2024) High glutamine increases stroke risk by inducing the endothelial\u2010to\u2010mesenchymal transition in moyamoya disease. MedComm (2020). https:\/\/doi.org\/10.1002\/mco2.525","journal-title":"MedComm (2020)"},{"key":"7471_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00308","author":"C Geng","year":"2020","unstructured":"Geng C, Cui C, Guo Y et al (2020) Metabolomic profiling revealed potential biomarkers in patients with moyamoya disease. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2020.00308","journal-title":"Front Neurosci"},{"key":"7471_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14254","author":"J Li","year":"2023","unstructured":"Li J, He Q, Liu C et al (2023) Integrated analysis of the association between methionine cycle and risk of moyamoya disease. CNS Neurosci Ther. https:\/\/doi.org\/10.1111\/cns.14254","journal-title":"CNS Neurosci Ther"},{"key":"7471_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fnins.2023.1158111","volume":"12","author":"J Li","year":"2023","unstructured":"Li J, Ge P, He Q et al (2023) Association between methionine sulfoxide and risk of moyamoya disease. Front Neurosci 12:17. https:\/\/doi.org\/10.3389\/fnins.2023.1158111","journal-title":"Front Neurosci"},{"key":"7471_CR15","doi-asserted-by":"publisher","unstructured":"Yu X, Ge P, Zhai Y et al (2023) Frontiers | Plasma urea cycle metabolite levels and the risk of moyamoya disease. Front Neurosci 17. https:\/\/doi.org\/10.3389\/fnins.2023.1163733","DOI":"10.3389\/fnins.2023.1163733"},{"key":"7471_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s007010070025","author":"A Noda","year":"2000","unstructured":"Noda A, Suzuki Y, Takayasu M et al (2000) Elevation of nitric oxide metabolites in the cerebrospinal fluid of patients with moyamoya disease. Acta Neurochir. https:\/\/doi.org\/10.1007\/s007010070025","journal-title":"Acta Neurochir"},{"key":"7471_CR17","doi-asserted-by":"publisher","DOI":"10.5853\/jos.2015.01760","author":"OY Bang","year":"2016","unstructured":"Bang OY, Fujimura M, Kim S-K (2016) The pathophysiology of moyamoya disease: an update. J Stroke. https:\/\/doi.org\/10.5853\/jos.2015.01760","journal-title":"J Stroke"},{"key":"7471_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2022.08.009","author":"C Asselman","year":"2022","unstructured":"Asselman C, Hemelsoet D, Eggermont D, Dermaut B, Impens F (2022) Moyamoya disease emerging as an immune-related angiopathy. Trends Mol Med. https:\/\/doi.org\/10.1016\/j.molmed.2022.08.009","journal-title":"Trends Mol Med"},{"key":"7471_CR19","doi-asserted-by":"publisher","unstructured":"Dorschel KB, Wanebo JE (2023) Frontiers | Physiological and pathophysiological mechanisms of the molecular and cellular biology of angiogenesis and inflammation in moyamoya angiopathy and related vascular diseases. Front Neurol 14. https:\/\/doi.org\/10.3389\/fneur.2023.661611","DOI":"10.3389\/fneur.2023.661611"},{"key":"7471_CR20","doi-asserted-by":"publisher","unstructured":"Guey S, Herv\u00e9 D, Kossorotoff M et al (2023) Biallelic variants in NOS3 and GUCY1A3, the two major genes of the nitric oxide pathway, cause moyamoya cerebral angiopathy - PubMed. Human Genom 17(1). https:\/\/doi.org\/10.1186\/s40246-023-00471-x","DOI":"10.1186\/s40246-023-00471-x"},{"issue":"8","key":"7471_CR21","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1161\/strokeaha.120.030027","volume":"51","author":"P Ge","year":"2020","unstructured":"Ge P, Zhang Q, Ye X et al (2020) Modifiable risk factors associated with moyamoya disease. Stroke 51(8):2472\u20132479. https:\/\/doi.org\/10.1161\/strokeaha.120.030027","journal-title":"Stroke"},{"issue":"1","key":"7471_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1161\/strokeaha.117.017430","volume":"49","author":"L Duan","year":"2018","unstructured":"Duan L, Wei L, Tian Y et al (2018) Novel susceptibility loci for moyamoya disease revealed by a genome-wide association study. Stroke 49(1):11\u201318. https:\/\/doi.org\/10.1161\/strokeaha.117.017430","journal-title":"Stroke"},{"key":"7471_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7806873","author":"DS Meena","year":"2018","unstructured":"Meena DS, Bohra GK, Meena M, Maheshwari BK (2018) Hyperhomocysteinemia in a patient with moyamoya disease. Case Rep Neurol Med. https:\/\/doi.org\/10.1155\/2018\/7806873","journal-title":"Case Rep Neurol Med"},{"key":"7471_CR24","doi-asserted-by":"publisher","unstructured":"Herrle N, Malacarne PF, Warwick T et al (2024) The transaminase-\u03c9-amidase pathway is a redox switch in glutamine metabolism that generates \u03b1-ketoglutarate. bioRxiv. https:\/\/doi.org\/10.1101\/2024.08.28.610061","DOI":"10.1101\/2024.08.28.610061"},{"key":"7471_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadva.2022.100066","author":"O Kostiuchenko","year":"2022","unstructured":"Kostiuchenko O, Lushnikova I, Kowalczyk M, Skibo G (2022) mTOR\/\u03b1-ketoglutarate-mediated signaling pathways in the context of brain neurodegeneration and neuroprotection. BBA Adv. https:\/\/doi.org\/10.1016\/j.bbadva.2022.100066","journal-title":"BBA Adv"},{"key":"7471_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2009.07.002","author":"S Jaisson","year":"2009","unstructured":"Jaisson S, Veiga-da-Cunha M, Schaftingen EV (2009) Molecular identification of \u03c9-amidase, the enzyme that is functionally coupled with glutamine transaminases, as the putative tumor suppressor Nit2. Biochimie. https:\/\/doi.org\/10.1016\/j.biochi.2009.07.002","journal-title":"Biochimie"},{"key":"7471_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-015-2061-7","author":"AJL Cooper","year":"2015","unstructured":"Cooper AJL, Shurubor YI, Dorai T et al (2015) \u03c9-Amidase: an underappreciated, but important enzyme in l-glutamine and l-asparagine metabolism; relevance to sulfur and nitrogen metabolism, tumor biology and hyperammonemic diseases. Amino Acids. https:\/\/doi.org\/10.1007\/s00726-015-2061-7","journal-title":"Amino Acids"},{"key":"7471_CR28","doi-asserted-by":"publisher","unstructured":"M\u00fcller N, M\u00fcller N (2022) The \u03c9-Amidase\/NIT2 is a novel redox-sensitive key regulator of glutamine metabolism in endothelial cells. https:\/\/doi.org\/10.21248\/gups.68954","DOI":"10.21248\/gups.68954"},{"issue":"3","key":"7471_CR29","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/archneur.1969.00480090076012","volume":"20","author":"J Suzuki","year":"1969","unstructured":"Suzuki J (1969) Cerebrovascular, \u201cmoyamoya\u201d disease. Arch Neurol 20(3):288. https:\/\/doi.org\/10.1001\/archneur.1969.00480090076012","journal-title":"Arch Neurol"},{"issue":"9","key":"7471_CR30","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.jpedsurg.2020.01.003","volume":"55","author":"SJ Staffa","year":"2020","unstructured":"Staffa SJ, Zurakowski D (2020) Strategies in adjusting for multiple comparisons: a primer for pediatric surgeons. J Pediatr Surg 55(9):1699\u20131705. https:\/\/doi.org\/10.1016\/j.jpedsurg.2020.01.003","journal-title":"J Pediatr Surg"},{"key":"7471_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-46763-z","author":"M Duggins-Warf","year":"2023","unstructured":"Duggins-Warf M, Ghalali A, Sesen J et al (2023) Disease specific urinary biomarkers in the central nervous system. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-023-46763-z","journal-title":"Sci Rep"},{"issue":"6","key":"7471_CR32","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1093\/neuonc\/noaa016","volume":"22","author":"PA Baxter","year":"2020","unstructured":"Baxter PA, Su JM, Onar-Thomas A et al (2020) A phase I\/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study. Neuro-oncol 22(6):875\u2013885. https:\/\/doi.org\/10.1093\/neuonc\/noaa016","journal-title":"Neuro-oncol"},{"issue":"14","key":"7471_CR33","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1158\/0008-5472.can-13-3116","volume":"74","author":"T Akino","year":"2014","unstructured":"Akino T, Han X, Nakayama H et al (2014) Netrin-1 promotes medulloblastoma cell invasiveness and angiogenesis, and demonstrates elevated expression in tumor tissue and urine of patients with pediatric medulloblastoma. Cancer Res 74(14):3716\u20133726. https:\/\/doi.org\/10.1158\/0008-5472.can-13-3116","journal-title":"Cancer Res"},{"issue":"6","key":"7471_CR34","doi-asserted-by":"publisher","first-page":"E1148","DOI":"10.1227\/01.Neu.0000255464.37634.3c","volume":"60","author":"ER Smith","year":"2007","unstructured":"Smith ER, Manfredi M, Scott RM, Black PM, Moses MA (2007) A recurrent craniopharyngioma illustrates the potential usefulness of urinary matrix metalloproteinases as noninvasive biomarkers: case report. Neurosurgery 60(6):E1148\u2013E1149. https:\/\/doi.org\/10.1227\/01.Neu.0000255464.37634.3c","journal-title":"Neurosurgery"},{"issue":"8","key":"7471_CR35","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1158\/1078-0432.ccr-07-1253","volume":"14","author":"ER Smith","year":"2008","unstructured":"Smith ER, Zurakowski D, Saad A, Scott RM, Moses MA (2008) Urinary biomarkers predict brain tumor presence and response to therapy. Clin Cancer Res 14(8):2378\u20132386. https:\/\/doi.org\/10.1158\/1078-0432.ccr-07-1253","journal-title":"Clin Cancer Res"},{"issue":"4","key":"7471_CR36","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3171\/2015.12.PEDS15448","volume":"18","author":"K Pricola Fehnel","year":"2016","unstructured":"Pricola Fehnel K, Duggins-Warf M, Zurakowski D et al (2016) Using urinary bFGF and TIMP3 levels to predict the presence of juvenile pilocytic astrocytoma and establish a distinct biomarker signature. J Neurosurg Pediatr 18(4):396\u2013407. https:\/\/doi.org\/10.3171\/2015.12.PEDS15448. (In English)","journal-title":"J Neurosurg Pediatr"},{"key":"7471_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2024.1442110","volume":"18","author":"K Ashok","year":"2024","unstructured":"Ashok K, Martinez T, Sesen J et al (2024) Lectin-type oxidized LDL receptor-1 as a potential therapeutic target for cerebral cavernous malformations treatment. Front Neurosci 18:1442110. https:\/\/doi.org\/10.3389\/fnins.2024.1442110. (In eng)","journal-title":"Front Neurosci"},{"issue":"6","key":"7471_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13164","volume":"33","author":"Y Pastorello","year":"2023","unstructured":"Pastorello Y, Carare RO, Banescu C, Potempa L, Di Napoli M, Slevin M (2023) Monomeric C-reactive protein: a novel biomarker predicting neurodegenerative disease and vascular dysfunction. Brain Pathol 33(6):e13164. https:\/\/doi.org\/10.1111\/bpa.13164. (In eng)","journal-title":"Brain Pathol"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-026-07471-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00381-026-07471-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-026-07471-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:03:42Z","timestamp":1790147022000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00381-026-07471-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7471"],"URL":"https:\/\/doi.org\/10.1007\/s00381-026-07471-x","relation":{},"ISSN":["1433-0350"],"issn-type":[{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"assertion":[{"value":"7 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"371"}}